Effects of propionic acid and pravastatin on HMG-CoA reductase activity in relation to forestomach lesions in the rat

Pharmacology and Toxicology

Volumn 78, Issue 4, 1996, Pages 229-234

  Bueld, J E ^a   Bannenberg, G ^a   Netter, K J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVINOLIN; PRAVASTATIN; PROPIONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FORESTOMACH; HYPERPLASIA; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH LESION;

ANIMALIA;

EID: 9244234418     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00210.x     Document Type: Article

References (29)

1. Avigan, J., S. J. Bhalthena & M. E. Schreiner: Control of sterol synthesis and of hydroxymethylglutaryl CoA reductase in skin fibroblasts grown from patients with homozygous type II hyperlipoproteinemia. J. Lipid Res. 1975, 16, 151-154.
2. Basler, A., W. von der Hude & M. Scheutwinkel: Screening of the food additive propionic acid for genotoxic properties. Fd. Chem. Toxic. 1987, 25, 287-290.
3. Blum, C. B.: Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Amer. J. Cardiol. 1994, 73, 3D-11D.
4. Bueld, J. E. & K. J. Netter: Factors affecting the distribution of ingested propionic acid in the rat forestomach. Fd. Chem. Toxic. 1993, 31, 169-176.
5. Bugaut, M. & M. Bentéjak: Biological effects of short-chain fatty acids in nonruminant mammals. Ann. Rev. Nutr. 1993, 13, 217-241.
6. Chen, W. J. L., J. E. Anderson & D. Jennings: Propionate may mediate Hypo-cholesterolaemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc. Soc. Exp. Biol. Med. 1984, 175, 215-218.
7. Grasso, P., M. Sharratt & A. J. Cohen: Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. Annu. Rev. Pharmacol. Toxicol. 1991, 31, 253-287.
8. Griem, W.: Study of the tumorigenic effect of propionic acid on the forestomach of mucosa of rats. Bundesgesundhbl. 1985, 28, 322-327.
9. Gärtner, K. & J. Pfaff: The forestomach in rats and mice, a food store without bacterial protein digestion. Zbl. Vet. Med. A. 1979, 26, 530-541.
10. Illman, R. J., D. L. Topping, G. H. McIntosh, R. P Trimble, G. B. Storer, M. N. Taylor & B. Q. Cheng: Hypocholesterolaemic effects of dietary propionate: studies in whole animals and perfused rat liver. Ann. Nutr. Metab. 1988, 32, 97-107.
11. Ito, N. L., S. L. Fukushima, A. L. Hagiwara, M. Shibata & T. Ogioso: Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst. 1983, 70, 343-352.
12. Joles, J., N. Willekes-Koolschijn, H. Koomans, A. Van-Tol, T. Geelhoed-Miera, D. Crommelin, L. Van-Bloois, M. Krajnc-Franken, L. Cohen, M. Griffioen & W. Erkelens: Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats. Lab. Anim. 1992, 26, 269-280.
13. Kloss, M. W., D. H. Patrick & J. S. MacDonald: Studied on the effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the rodent forestomach. Fd. Chem. Toxic. 1991, 29, 621-628.
14. Koga, T., Y. Shimada, M. Kuroda, Y. Tssujita, K. Hasegawa & M. Yamazaki: Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim. Biophys. Acta 1990, 1045, 115-120.
15. Mori, K.: Production of gastric lesions in the rat by the diet containing fatty acids. Gann 1953, 44, 421-427.
16. Mosley, S. T., S. S. Kalinowski, B. L. Schafer & R. D. Tanaka: Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase on cholesterol biosynthesis in lens. J. Lipid Res. 1989, 30, 1411-1420.
17. Pan, H. Y., A. R. DeVault, D. Wang-Iversen, E. Ivashkiv, B. N. Swanson & A. A. Sugerman: Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J. Clin. Pharmacol. 1990, 30, 1128-1135.
18. Parker, R. A., R. W. Clark, S-Y Sit, T. L. Lanier, R. A. Grosso & J. J. K. Wright: Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors. J. Lipid Res. 31, 1271-1282.
19. Popov, N., M. Schmitt, S. Schulzek & H. Matthies: Eine störungsfreie Mikromethode zur Bestimmung des Proteingehaltes in Gewebehomogenaten. Acta Biol. Med. Ger. 1975, 34, 1441-1446.
20. Reihnér, E., M. Rudling, D. Stahlberg, L. Berglund, S. Ewerth, I. Björkhem, K. Einarsson & B. Angelin: Influence of pravastatin a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. New Engl. J Med. 1990, 323, 224-228.
21. Roth, B. D., T. M. A. Bocan, C. J. Blankley, A. W. Chucholowski, P. L. Creger, M. W. Creswell, E. Ferguson, R. S. Newton, P. O'Brien, J. A. Picard, W. H. Roark, C. S. Sekerke, D. R. Sliskovic & M. W. Wilson: Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase. J. Med. Chem. 1991, 34, 463-466.
22. Shapiro, D. J., J. L. Nordstrom, J. J. Mitschelen, V. W. Rodwell & R. T. Schimke: Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. Biophys. Acta 1974, 370, 369-377.
23. Singer, I. I., D. K. Kawaka, S. Scott, P. Bailey, M. W. Kloss, J. Majka & J. S. MacDonald: Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase induce accumulation and altered lamellar bodies in rat forestomach keratinocytes. Arteriosclerosis and Thrombosis 1991, 11, 1156-1165.
24. Tsujita, Y. & Y. Watanabe: Pravastatin sodium: a novel cholesterol-lowering agent that inhibitis HMG-CoA reductase. Cardiovascular Drug Rev. 1989, 7, 110-126.
25. Tsujita, Y., M. Kuoda, Y. Shimada, K. Tanzawa, M. Arai, I. Kaneko, M. Tanaka, H. Masuda, C. Tarumi, Y. Watanabe & S. Fujii: CS-514, a competitive inhibitor of 3-hydroxyl-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis & hypolipidemic effect on various animal species. Biochem. Biophys. Acta 1986, 877, 50-60.
26. +-independent multispecific anion transporter of pravastatin into rat liver. Amer. J. Physiol. 1993, 27, G 36-42.
27. Yamauchi, S., W. G. Linscheer, D. H. Beach: Increase in serum and bile cholesterol and HMG-CoA reductase by lovaslatin in rats. Amer. J. Physiol. 1991, 23, G 625-630.
28. Yoshino, G., T. Kazumi, M. Kasama, I. Iwai, K. Iwatani, M. Matsuba, M. Matsushita & S. Baba: Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats. Atherosclerosis 1988, 73, 191-195.
29. Ziegler, K. & W. Stünkel: Tissue-selective action of pravastatin due to hepatocellular uptake via sodium-independent bile acid transporter. Biochim. Biophys. Acta 1992, 1139, 203-209.